Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-10-10
|
pubmed:abstractText |
The effect of sustained intrastriatal release of dopamine (DA) from polymer matrices on apomorphine-induced turning behavior in a 6-hydroxydopamine (6-OHDA) unilaterally lesioned rat model was analyzed. A biocompatible semipermeable tube was placed in a denervated striatum as a receptacle for DA-releasing polymer rods. In vitro kinetics showed sustained release of DA from a polymeric rod for 15 days. Implantation of a DA-releasing rod within the striatal receptacle significantly decreased apomorphine-induced rotational behaviour in lesioned animals. Upon removal of the DA-releasing system from the receptacle, rotational behaviour increased within 2 weeks and approached preimplant control values 4 weeks later. Acute microdialysis revealed that DA appeared in the extracellular space within 20 min after the implantation of a DA-releasing rod into a denervated striatum. Significant DA amounts were still measurable 7 days postimplantation, indicating sustained DA release from the polymer rod. Dopamine released from a polymer matrix through a semipermeable receptacle alleviates experimental parkinsonism in rats, suggesting that controlled intrastriatal release of DA from a polymer matrix may provide an alternative method for the treatment of Parkinson's disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acrylic Resins,
http://linkedlifedata.com/resource/pubmed/chemical/Apomorphine,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Implants,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxydopamines,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidopamine,
http://linkedlifedata.com/resource/pubmed/chemical/Polyvinyls
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0014-4886
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
244-50
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2504616-Acrylic Resins,
pubmed-meshheading:2504616-Animals,
pubmed-meshheading:2504616-Apomorphine,
pubmed-meshheading:2504616-Brain,
pubmed-meshheading:2504616-Corpus Striatum,
pubmed-meshheading:2504616-Disease Models, Animal,
pubmed-meshheading:2504616-Dopamine,
pubmed-meshheading:2504616-Drug Implants,
pubmed-meshheading:2504616-Hydroxydopamines,
pubmed-meshheading:2504616-Male,
pubmed-meshheading:2504616-Motor Activity,
pubmed-meshheading:2504616-Oxidopamine,
pubmed-meshheading:2504616-Parkinson Disease,
pubmed-meshheading:2504616-Parkinson Disease, Secondary,
pubmed-meshheading:2504616-Polyvinyls,
pubmed-meshheading:2504616-Rats,
pubmed-meshheading:2504616-Rats, Inbred Strains
|
pubmed:year |
1989
|
pubmed:articleTitle |
An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats.
|
pubmed:affiliation |
Artificial Organ Laboratory, Brown University, Providence, Rhode Island 02912.
|
pubmed:publicationType |
Journal Article
|